Medication info
Hepabite F Soft Capsule

Hepabite F Soft Capsule

OTC medicationSoft capsule경구
Ingredient · strength
Milk-Thistle Fruit Dried Extract›100mg / 1 capsuleThiamine Hydrochloride›4mg / 1 capsuleRiboflavin›4mg / 1 capsulePyridoxine Hydrochloride›4mg / 1 capsuleNicotinamide›12mg / 1 capsuleCalcium Pantothenate›8mg / 1 capsuleCyanocobalamin Powder 0.1%›1.2mg / 1 capsule
Manufacturer / importer
(주)바스칸바이오제약
Appearance
Brownish black soft capsule containing yellow-brown contents
Packaging
1 capsule/pack, 300 capsules/box [1 capsule/pack × 300]
Approval status
Active

MFDS item code 200404781 · Notified 2004.11.18

Summary

Main use
Adjunctive treatment for chronic and toxic liver diseases
Who takes it
Adults
Adult dose
Adults: 1 capsule at a time, taken 3 times a day. After treatment, reduce the dosage to 1-2 capsules per day.

Ingredients

Manufacturer
(주)바스칸바이오제약

Efficacy & effects

Adjunctive treatment for chronic and toxic liver diseases

  • Chronic liver disease
  • toxic liver disease
View approved original text

This medication is used as an adjunctive treatment for chronic liver diseases and toxic liver diseases.

How to take

Adult dose

Adults: 1 capsule at a time, taken 3 times a day. After treatment, reduce the dosage to 1-2 capsules per day.

Precautions

This medication should not be taken by individuals allergic to soybean oil or who show hypersensitivity. People allergic to soybeans or peanuts should also avoid this medication. Pregnant women should consult a physician or pharmacist before taking this medication, as although animal studies have not shown risks to the fetus, sufficient studies in pregnant women have not been conducted. Patients with metabolic disorders such as hyperlipidemia, diabetic dyslipidemia, or pancreatitis should consult a specialist before taking this medication. This medication contains Yellow No. 4 (Tartrazine) as a coloring agent, and those allergic to this ingredient should exercise caution. If diarrhea or other unusual symptoms occur during use, stop taking the medication immediately and consult a doctor. If symptoms do not improve after about a month of use, it is important to consult a specialist. The prescribed dosage and administration must be strictly adhered to, and especially when administering to children, adult supervision is required. Patients at risk of fat overload should regularly monitor blood lipid levels and adjust dosages accordingly. When used in conjunction with other injectable lipid preparations, the lipid content in this medication should be considered when adjusting dosages. When storing, keep out of reach of children, avoid direct sunlight, and store in a cool, dry place. Additionally, transferring the medication from its original container to another can lead to misuse or deterioration of quality, so it should be avoided.

Side effects and when to seek care immediately

Mild side effects

Possible diarrhea, occurrence of unusual symptoms

Not everyone experiences these, and they can vary from person to person.

Interactions

Drug interactions

This medication should be discussed with a physician or pharmacist if taken in conjunction with intravenous lipid preparations.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain storage temperatures between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and safety over time.

Appearance and packaging

Appearance

Brownish black soft capsule containing yellow-brown contents

Package unit

1 capsule/pack, 300 capsules/box [1 capsule/pack × 300]

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.